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mmune-mediated necrotizing myopathy is a rare and
ecently described form of idiopathic inﬂammatory myopa-
hy, characterized as a necrotizing myopathy with minimal or
o inﬂammatory inﬁltrate on muscle biopsy. The clinical fea-
ures of symmetrical proximal muscle weakness and acute or
ubacute onset may be misunderstood with polymyositis or
ermatomyositis. This condition has a wide range of reported
utcomes, from fast progression with no remission to com-
lete recovery. To the best of our knowledge up to date there
s no case reported in Brazil of immune-mediated necrotizing
yopathy, and no one in Latin America related to cancer. Here
e  described a case of paraneoplastic necrotizing myopathy
econdary a tubo-ovarian adenocarcinoma.Please cite this article in press as: Ferraz AP, José FF. Paraneoplastic 
http://dx.doi.org/10.1016/j.rbre.2013.10.007
ase  report
 61-year-old woman, married, white, was admitted with
he chief complaint of pain and progressive weakness of the
ower limbs, with ascension to upper members, of 4 weeks of
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icenses/by-nc-nd/4.0/).development, associated with dysphagia and dysphonia. She
also reported weight loss of 10 kg in that period. She previ-
ously had hypertension and hypothyroidism. She underwent
a total hysterectomy 21 years ago due to uterine leiomyomato-
sis. She also underwent bariatric surgery, abdominoplasty and
mammaplasty for about 9 years. There was no history of alco-
holism, smoking or use of recreational drugs. The family his-
tory was positive for acute myocardial infarction and stroke.
On physical examination the patient was afebrile and
appeared well. The pulse was 68 bpm, the blood pressure
130 × 85 mmHg, breathing frequency of 20 incursions per
minute. The lungs and heart were normal. There was a pres-
ence of a median scar on abdomen. Edema of lower limbs and
plastering of calves were absent. Neurological examination
showed a weakness of proximal muscles graduated in 2 and
weakness of distal muscles graduated in 4 on a scale of 0–5.
The deep tendon reﬂexes were graduated in 1 on a scale of 0–4.
The plantar cutaneous reﬂex was in ﬂexion bilaterally. Therenecrotizing myopathy – a case report. Rev Bras Reumatol. 2016.
were no other abnormalities on neurological examination.
Additional laboratory evaluation showed a creatine kinase
of 7874 U/l (normal range: 26–192), lactic acid dehydrogenase
1350 U/l (reference: <50), aspartate aminotransferase 452 U/l
e under the CC BY-NC-ND license (http://creativecommons.org/
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Fig. 1 – Necrosis with macrophagy (asterisk), nuclear
centralization (arrowhead), regenerating ﬁbers (arrows) and
atrophic ﬁber (circle), in the absence of inﬂammatory
inﬁltrate. HE X250. Given by Dr. Beny Schmidt, associate
professor of pathological anatomy, chief of the
Fig. 2 – Filling defects of segmental branches of the right
lower lobe and left lower lobe due to pulmonaryNeuromuscular Laboratory – UNIFESP.
(<32), alanine aminotransferase 679 U/l (<33). Serological tests
for hepatitis B and C and for HIV were negative. In immuno-
logical parameters, the antinuclear factor was positive with
a speckled pattern, titer of 1/160, but anti-JO and anti-
native DNA antibody, anti-ribonucleoprotein, anti-Ro, anti-La,
anti-SCL70 were negative. Cerebrospinal ﬂuid analysis was
positive for neoplastic cells. The level of CA125 was increased:
6013 U/mL (reference: <35).
Electromyography showed a pattern of predominantly
proximal myopathy, polyphasic motor unit potentials reduced
in amplitude and duration. Biopsy of the deltoid muscle
revealed atrophy of muscle ﬁbers, with homogeneous necrosis
and the presence of macrophagy, with absence of inﬂam-
matory inﬁltrate (Fig. 1). The search for malignancies of
gastrointestinal tract by upper gastrointestinal endoscopy
and colonoscopy resulted negative. Screening for breast can-
cer with mammography and research of tumor marker CA
15.3 was negative. Computed tomography (CT) of the chest
showed bilateral pulmonary thromboembolism, reinforcing
the idea of underlying malignancy neoplasia (Fig. 2). A CT
of the abdomen and pelvis showed retroperitoneal lym-
phadenopathy involving the chain interaortocaval, pelvic
lymphadenopathy and lymphonodes around the bladder. MRI
of the abdomen and pelvis showed the presence of retroperi-
toneal node 6 centimeters of larger diameter and the presence
of vascularized solid nodule in the right ovary. Magnetic reso-
nance imaging of the skull and spine showed no neoplastic
focus. White matter of the brain hemispheres had foci of
ischemia, while column showed degenerative changes, as well
as atrophy of the posterior paraspinal muscle groups, with
replacement of muscle ﬁbers by fat, especially in the lumbarPlease cite this article in press as: Ferraz AP, José FF. Paraneoplastic 
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spine.
The biopsy of the retroperitoneal mass showed adenocar-
cinoma inﬁltration. The patient then underwent exploratory
laparotomy with bilateral oophorectomy, resection ofthromboembolism.
paraaortic mass, omentectomy and pelvic lymphadenec-
tomy. The study by immunohistochemistry concluded that
it was a right tubo-ovarian high-grade serous carcinoma
with metastasis to the left ovary, periaortic lymphonodes and
omentum. The patient died 2 weeks after surgery due to sepsis
after severe pancytopenia, possibly due to neoplastic marrow
inﬁltration, although bone marrow biopsy for conﬁrmation
was not performed.
Discussion
Immune-mediated necrotizing myopathy is now recognized
as part of the group of Idiopatic Inﬂammatory Myopathies
that include polymyositis, dermatomyositis, sporadic inclu-
sion body myositis, juvenile dermatomyositis and amyopathic
and hypomyopathic dermatomyositis. This uncommon condi-
tion is frequently confused with polymyositis because of their
symptoms of weakness of proximal muscles and high levels
of creatine kinase.1 It may occur in several settings, includ-
ing viruses, connective tissue diseases, in association with the
use of certain drugs, including statins and as a paraneoplastic
disorder.
The Immune-mediated necrotizing myopathy that occurs
in association with use of statins persists despite drug dis-
continuation, unlike the more  typical statin-related myopathy
that resolves after drug discontinuation. In comparison to the
toxic myopathy, the course of a necrotizing myopathy may
be self-limited, and recovery may occur after the offending
agent is discontinued, occasionally over weeks to months.
Like polymyositis and dermatomyositis, it may precede the
identiﬁcation of a tumor. The most common cancers are
gastrointestinal tumors, small cell lung cancer, and breast
cancer.2
These patients may have high elevations of creatine kinase
levels, greater than 10 times the upper limits of normal, with
acute or subacute onset of symptoms, although a chronic
disease course may also occur. In the physical examination
proximal muscle weakness is found.1 As with other idio-necrotizing myopathy – a case report. Rev Bras Reumatol. 2016.
pathic inﬂammatory myopathies, electromyography should
be performed to conﬁrm a myopathic process characterized by
polyphasic motor unit action potentials of short duration and
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ow amplitude with increased insertional and spontaneous
ctivity with ﬁbrillation potentials, sharp waves, or repetitive
ischarges and to target a muscle for biopsy. It is recom-
ended that the same muscle on the opposite side should
e chosen for biopsy.1
The pathophysiology of this disease is still incom-
letely understood. Statin-induced necrotizing myopathy has
een associated with an antibody against the 3-hydroxy-3-
ethylglutaryl-coenzyme A reductase (HMGCR) protein that
s upregulated in regenerating muscle ﬁbers.1 T cell-mediated
mmune responses as well as humoral factors may be
nvolved. The small number of inﬂammatory cells in muscle
pecimens of patients with necrotizing myopathy raises the
ossibility of a toxic molecule mediating the syndrome, but
he response to steroids or immunoglobulins is more  compat-
ble with an immune-mediated process.3
Histopathologically, in paraneoplastic necrotizing
yopathies an heterogeneous pattern of necrosis are found,
anging from sparse, segmental necrotic lesions to massive
ecrosis.2,4,5 Macrophages surround necrotic muscle ﬁbers,
nd atrophic and regenerating ﬁbers are present. Immuno-
taining reveals Tlymphocytes (CD3) and macrophages (CD68)
round necrotic and regenerating muscle ﬁbers.1
Despite the new evidences, it has recently been shown
ow rheumatologists and neurologists often differ in clas-
iﬁcation of myopathies. While neurologists are specialized
n diagnosis utilizing electromyography and muscle biopsy
nterpretation, rheumatologists, on the contrary, are typi-
ally trained in making a clinical diagnosis, understanding
he role of autoantibody association.6 Nevertheless, effective
ommunication and synergy between subspecialists, using
oth strategies to make diagnosis and to classify, is nowadays
equired to improve communication and achieve consistent
onclusion in clinical trials.
onclusion
mmune-mediated necrotizing myopathy secondary to statin
7Please cite this article in press as: Ferraz AP, José FF. Paraneoplastic 
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as already been reported in Latin America by Opazo et al, but
ntil our present knowledge this is the ﬁrst case of immune-
ediated necrotizing myopathy reported in Brazil and the ﬁrst
elated to neoplasia in Latin America.
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This case report emphasizes the need for clinical sus-
picion of cancer in patients with idiopathic inﬂammatory
myopathies and highlights the immune-mediated necrotizing
myopathy, one of its more  recently described clinical forms.
The case showed good correlation with what is found in the lit-
erature regarding the clinical manifestations. Ovarian cancer
is not the neoplasm most commonly found in paraneoplas-
tic necrotizing myopathies. Therefore, this case demonstrates
the need to investigate other sites beyond gastrointestinal,
lung and breast. The recovery of the symptoms of muscle
weakness after treatment of the underlying cancer could not
be assessed due to the advanced cancer stage of the patient.
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